CL

CL

USD

Colgate-Palmolive Company Common Stock

$76.550+0.750 (0.989%)

Цена в режиме реального времени

Consumer Defensive
Household & Personal Products
Соединенные Штаты

График цен

Loading Chart...

Ключевые показатели

Рыночные показатели
Фундаментальные показатели компании
Статистические данные торговли

Рыночные показатели

Открытие

$75.800

Максимум

$76.585

Минимум

$75.000

Объем

6.40M

Фундаментальные показатели компании

Рыночная капитализация

61.7B

Отрасль

Household & Personal Products

Страна

United States

Статистические данные торговли

Средний объем

5.80M

Биржа

NYQ

Валюта

USD

52-недельный диапазон

Минимум $74.55Текущая $76.550Максимум $100.18

Отчет об анализе ИИ

Последнее обновление: 2 нояб. 2025 г.
Сгенерировано ИИИсточник данных: Yahoo Finance, Bloomberg, SEC

Colgate-Palmolive (CL): Mixed Signals Near Key Support Level

Company Overview

Colgate-Palmolive (CL), a leader in household and personal care products, operates with 34,000 employees across categories like oral hygiene, pet nutrition, and home care. Its current stock price ($76.51) sits near a 52-week low ($74.62), with a market cap of $62.3B and a P/E ratio of 19.96. The company recently cut its annual sales forecast, citing weak consumer demand, after reporting Q3 revenue growth of 1.9%--below analyst expectations.


Price Action Review

Over the past three months:

  • Trend: Bearish. Shares dropped 10.8% from $85.78 (Aug 20) to $76.51 (Oct 31).
  • Volatility: Low (avg volume: 5.7M shares), though sudden sell-offs occurred in late October (e.g., $79.86 → $77.14 in 3 days).
  • Key Levels:
  • Support: $76.37 (Bollinger Band lower bound).
  • Resistance: $85.43 (Oct 20 high) and $88.84 (analyst price target).

Technical indicators suggest a bullish breakout is possible if prices hold above $74.95 (stop-loss level). The MACD golden cross and surging On-Balance Volume (15.4x average) hint at short-term buying pressure.


News Sentiment Analysis

Recent headlines show conflicting signals:

  • Negative: CL lowered its annual sales forecast on Oct 31, citing "rising economic uncertainty" impacting demand for premium-priced products--even in essentials like toothpaste.
  • Neutral: Q3 organic sales rose just 0.4%, dragged down by a "non-strategic exit from private-label pet sales."
  • Positive: JP Morgan reiterated an "Overweight" rating on Oct 10, though cutting its price target from $95 to $88.

Analyst sentiment remains optimistic

Связанные новости

Analyst Upgrades

Barclays Maintains Equal-Weight on Colgate-Palmolive, Lowers Price Target to $80

Barclays analyst Lauren Lieberman maintains Colgate-Palmolive with a Equal-Weight and lowers the price target from $82 to $80.

Просмотреть больше
Barclays Maintains Equal-Weight on Colgate-Palmolive, Lowers Price Target to $80
Reuters

Procter & Gamble can be sued over Kid's Crest packaging, US judge rules

Procter & Gamble must face a lawsuit alleging that its packaging for Kid's Crest suggests that children can use more of the toothpaste than is safe.

Просмотреть больше
Procter & Gamble can be sued over Kid's Crest packaging, US judge rules
Analyst Upgrades

UBS Maintains Buy on Colgate-Palmolive, Lowers Price Target to $90

UBS analyst Peter Grom maintains Colgate-Palmolive with a Buy and lowers the price target from $92 to $90.

Просмотреть больше
UBS Maintains Buy on Colgate-Palmolive, Lowers Price Target to $90
Analyst Upgrades

Citigroup Maintains Buy on Colgate-Palmolive, Lowers Price Target to $95

Citigroup analyst Filippo Falorni maintains Colgate-Palmolive with a Buy and lowers the price target from $105 to $95.

Просмотреть больше
Citigroup Maintains Buy on Colgate-Palmolive, Lowers Price Target to $95
Analyst Upgrades

Morgan Stanley Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $87

Morgan Stanley analyst Dara Mohsenian maintains Colgate-Palmolive with a Overweight and lowers the price target from $96 to $87.

Просмотреть больше
Morgan Stanley Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $87
Analyst Upgrades

JP Morgan Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $87

JP Morgan analyst Andrea Teixeira maintains Colgate-Palmolive with a Overweight and lowers the price target from $88 to $87.

Analyst Upgrades

Evercore ISI Group Maintains Outperform on Colgate-Palmolive, Lowers Price Target to $94

Evercore ISI Group analyst Robert Ottenstein maintains Colgate-Palmolive with a Outperform and lowers the price target from $100 to $94.

Прогноз ИИBeta

Рекомендация ИИ

Медвежий

Обновлено в: 5 нояб. 2025 г., 07:26

МедвежийНейтральныйБычий

64.8% Уверенность

Риск и торговля

Уровень риска3/5
Средний риск
Подходит для
Консервативный
Руководство по торговле

Точка входа

$76.25

Взять прибыль

$78.60

Остановить убытки

$74.86

Ключевые факторы

PDI 10.5 выше MDI 4.8 с ADX 24.3, что предполагает бычий тренд
Текущая цена очень близка к уровню поддержки ($76.37), что предполагает сильную возможность покупки
Объем торгов в 13.4 раз превышает среднее значение (70,707), что указывает на чрезвычайно сильное покупательское давление
MACD 0.2771 выше сигнальной линии 0.2137, что указывает на бычье пересечение

Оставаться в курсе

Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.